Search results for abx831499

Toripalimab, Abbexa, abx831499

Toripalimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting PDCD1/PD1/CD279, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Toripalimab is a humanized monoclonal antibody that targets programmed death receptor 1 (PD-1). It is used to treat patients with unresectable or metastatic melanoma who have previously failed systemic therapy. It is intended for treatment Breast cancer, lymphoma, malignant melanoma, genitourinary system cancer and other types of solid tumors.